<!--
title: Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients
description: doi: 10.1016/j.ijcard.2021.08.018
published: true
date: 2022-02-11T10:33:16.817Z
tags: side, effects, effect, risk, mrna, adverse, bnt162b2, covid19, covid, vaccines, myocarditis, hyperinflammation, inflammation
editor: ckeditor
dateCreated: 2022-02-11T10:33:16.817Z
-->

<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372420/#">Int J Cardiol.</a> 2021 Oct 1; 340: 119–121.</p>
<p>Published online 2021 Aug 18. doi:&nbsp;<a href="https://dx.doi.org/10.1016%2Fj.ijcard.2021.08.018">10.1016/j.ijcard.2021.08.018</a></p>
<p style="text-align:right;">PMCID: PMC8372420</p>
<p style="text-align:right;">PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/34416319">34416319</a></p>
<p>&nbsp;</p>
<h1>Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients</h1>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Abbate%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Antonio Abbate</a>,<sup>a,1,⁎</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Gavin%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Josh Gavin</a>,<sup>b,1,⁎</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Madanchi%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Nima Madanchi</a>,<sup>b</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Kim%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Christin Kim</a>,<sup>c</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Shah%20PR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Pranav R. Shah</a>,<sup>c</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Klein%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Katherine Klein</a>,<sup>d</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Boatman%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Julie Boatman</a>,<sup>e</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Roberts%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Charlotte Roberts</a>,<sup>a</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Patel%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Seema Patel</a>,<sup>b</sup> and <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Danielides%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34416319">Stamatina Danielides</a><sup>b</sup></p>
<p>&nbsp;</p>
<h2>Abstract</h2>
<p>Immune-mediated myocardial injury following Severe Acute Respiratory Syndrome Coronavirys-2 (SARS-CoV2) infection has been described in adults and children. Cases of myocarditis following immunization for SARS-CoV2 have recently been documented, mostly associated with mild severity and spontaneous recovery. We herein report two cases of fulminant myocarditis following BNT162b2 mRNA Covid-19 vaccination associated with systemic hyperinflammatory syndrome and refractory shock requiring support with veno-arterial extracorporeal membrane oxygenation.</p>
<p>&nbsp;</p>
<p>Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372420/</p>
